Scarica l'app Stockscreener
3.43
4.89%
0.16
Dopo l'orario di chiusura:
3.49
0.06
+1.75%
Nrx Pharmaceuticals Inc Borsa (NRXP) Ultime notizie
NRX Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
NRX Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
NRx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET - Investing News Network
NRX Pharmaceuticals Q2 Results: EPS Misses Estimate, Sales Fall 94% - scanx.trade
NRX Pharmaceuticals reports $18.0M net loss for first half 2026, $26.7M cash on hand - TradingView
Five million ketamine doses are in production—but when can sales start? - Stock Titan
NRx Pharmaceuticals, Inc. (NRXP) reports Q2 loss, misses revenue estimates - FXStreet
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
NRx Pharmaceuticals (NASDAQ:NRXP) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
NRx Pharmaceuticals (NASDAQ:NRXP) Issues Earnings Results, Misses Estimates By $0.35 EPS - MarketBeat
NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
NRx Pharmaceuticals (NRXP) grows clinic revenue, flags going concern risk - Stock Titan
NRXP Stock Price, Quote & Chart - ChartMill
NRX Pharmaceuticals Inc expected to post earnings of 6 cents a shareEarnings Preview - TradingView
NRXP Q2'26 Earnings: EPS estimate is (0.11) USD - TradingView
NRX Pharmaceuticals Inc (NRXP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GOOGL Stock Price TodayAlphabet Inc Class A News, Charts, Retail Sentiment - Stocktwits
H.C. Wainwright reiterates NRx Pharmaceuticals stock rating at buy By Investing.com - Investing.com UK
NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles - MarketBeat
Transcript : NRx Pharmaceuticals, Inc.Special Call - marketscreener.com
H.C. Wainwright reiterates NRx Pharmaceuticals stock rating at buy - Investing.com
NRx Pharmaceuticals (NRXP) Projected to Post Quarterly Earnings on Monday - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and Pfizer (PFE) - The Globe and Mail
NRx Advances FDA Review of Ketamine ANDA Packaging Issue - The Globe and Mail
NRX Pharmaceuticals Inc (NRXP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NRx Pharmaceuticals completes FDA first-cycle ANDA review By Investing.com - Investing.com South Africa
NRx Pharmaceuticals to discuss FDA review and c... - Pluang
NRx Pharmaceuticals to Host Conference Call on FDA First-Cycle Review of Preservative-Free Ketamine ANDA - Quiver Quantitative
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans - The Manila Times
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference - GlobeNewswire
NRx Pharmaceuticals Shares Rise After FDA Finishes Ketamine Review - Moomoo
BTIG Research Cuts NRx Pharmaceuticals (NASDAQ:NRXP) Price Target to $10.00 - MarketBeat
FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP) - FinancialContent
NRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ) - Seeking Alpha
NRX Pharmaceuticals Inc. R (B1Q.MU) Q1 FY2026 earnings call transcript - Yahoo Finance
NRx Pharmaceuticals completes FDA first-cycle ANDA review - Investing.com
FDA Completes First-Cycle Review of Preservative-Free - GlobeNewswire
Certain Warrants of NRx Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 3-AUG-2026. - marketscreener.com
12 Health Care Stocks Moving In Friday's After-Market Session - Sahm
NRX Pharmaceuticals Inc (NRXP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NRX Pharmaceuticals Market Sentiment - Benzinga España
NRX Pharmaceuticals Inc (NRXP) Valuation: PE, PB & Fair Value Analysis - TradingKey
NRX Pharmaceuticals Inc (NRXP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
NRX Pharmaceuticals Inc (NRXP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NRX Pharmaceuticals Inc (NRXP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NRX Pharmaceuticals Inc (NRXP) Cash Flow - TradingKey
NRXP|NRX Pharmaceuticals Inc|Price:3.340|Chg%:-0.020 - tradingkey.com
TradingKey - TradingKey
NRX Pharmaceuticals, Inc. Revenue Breakdown – MUN:B1Q - TradingView
NRX Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:NRXP - TradingView
NRX Pharmaceuticals, Inc. Revenue Breakdown – FWB:B1Q - TradingView
NRX Pharmaceuticals Inc (B1Q.HM) stock price, news, quote and history - Yahoo Finance UK
NRX Pharmaceuticals Inc (B1Q.HM) stock major holders - Yahoo Finance UK
NRx Pharmaceuticals Selected by DARPA for Innovative SPARC-TMS Clinical Trial to Treat Depression - Minichart
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
NRx Pharmaceuticals (NASDAQ:NRXP) Shares Up 0.7%Time to Buy? - MarketBeat
Market Sentiment Around Loss-Making NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) - Sahm
Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation? - Yahoo Finance
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):